Skip to main content
. 2021 Aug 5;36(31):e228. doi: 10.3346/jkms.2021.36.e228

Fig. 1. The brain magnetic resonance imaging (MRI) of a 22-year-old patient who received the first dose of SARS-CoV-2 mRNA vaccine (BNT162b) 3-days prior coming to the hospital. (A, B) The brain images show an oval-shaped restricted diffusion in the corpus callosum with low apparent diffusion coefficient (ADC) values. The patient was diagnosed with cytotoxic lesion of the corpus callosum (CLOCCs) after SARS-CoV-2 mRNA vaccination.

Fig. 1